etoposide has been researched along with Kidney Neoplasms in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (5.41) | 18.7374 |
1990's | 35 (31.53) | 18.2507 |
2000's | 44 (39.64) | 29.6817 |
2010's | 24 (21.62) | 24.3611 |
2020's | 2 (1.80) | 2.80 |
Authors | Studies |
---|---|
Bastow, KF; Cheng, HH; Ito, J; Lee, KH; Luo, TY; Nakanishi, Y; Tachibana, Y; Wang, HK; Xu, Z | 1 |
Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
Chatziantoniou, A; Christodoulou, P; Drenios, C; Ioannou, I; Kourti, M; Zaravinos, A | 1 |
Chen, C; Chen, ZP; Liu, TS; Xia, BW; Yan, Y; Zhou, B | 1 |
Block, K; Friedrichs, WE; Kaushik, D; Nayak, BK; Rodriguez, R; Shanmugasundaram, K | 1 |
Yan, Y; Yang, WZ; Zhou, H | 1 |
Asanuma, H; Shima, H; Shimada, H; Yamada, Y | 1 |
Carden, MA; Greenberg, J; McCarty, JM; Perdahl-Wallace, E | 1 |
Anderson, JR; Chi, YY; Green, DM; Grundy, PE; Kalapurakal, JA; Miser, J; Perlman, EJ; Ritchey, ML; Seibel, NL; Sun, J; Thomas, PR; Tian, J | 1 |
Dauphin, G; de Araujo, PC; Demarche, M; Forget, P; Leroy, P; Rausin, L | 1 |
Bharatam, PV; Choudhuri, M; Das, D; Guchhait, SK; Jain, V; Kandekar, S; Kashyap, M; Kundu, CN; Mohapatra, P; Preet, R; Renu Prasad, MU; Satapathy, SR; Siddharth, S | 1 |
Demir, AH; Emir, S; Karakuş, E; Özcan, F; Özyörük, D; Senayli, A; Tiryaki, T | 1 |
Li, T; Mao, GJ; Sun, H; Sun, LL; Zhang, Y | 1 |
Beck, JF; Ebinger, M; Feuchtinger, T; Furtwängler, R; Greil, J; Handgretinger, R; Illhardt, T; Klingebiel, T; Lang, P; Schlegel, PG; Schwarze, CP | 1 |
Chen, J; Cui, MH; Han, LY; Jia, ZH; Miao, LN; Teng, H; Wang, L; Zhang, Y; Zhu, H | 1 |
Mo, J; Murphy, EP; Yoon, JM | 1 |
Lee, AC | 1 |
Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH | 1 |
Ayas, S; Cetiner, H; Gurbuz, A; Karateke, A | 1 |
Daw, NC; Gregornik, D; Jenkins, JJ; Jones, DP; Kun, LE; Marina, N; McPherson, V; Rodman, J; Wilimas, J; Wu, J | 1 |
Hara, T; Hatano, M; Kinoshita, Y; Koga, Y; Kohashi, K; Matsuzaki, A; Oda, Y; Saito, Y; Suminoe, A; Taguchi, T; Tajiri, T; Tsuneyoshi, M | 1 |
Al-Hussaini, M; Ali, HM; Almousa, A; Ghandour, K; Ismael, T; Masarweh, M; Rodriguez-Galindo, C; Sultan, I | 1 |
Akkaya, E; Macaulay, VM; Peak, S; Protheroe, AS; Sullivan, M; Takiguchi, M; Wang, Y; Yuen, JS | 1 |
Inoue, K; Kamada, M; Kuno, T; Nishigawa, H; Ookouchi, H; Shuin, T; Tamura, K; Yoshimichi, J | 1 |
He, DW; Li, XL; Lin, T; Liu, JH; Liu, X; Wei, GH; Zhang, DY | 1 |
Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M | 1 |
Brown, E; Hebra, A; Hudspeth, M; Jenrette, J | 1 |
El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
Athanasopoulos, A; Daladimos, T; Karabelis, A; Kosmas, C; Mylonakis, N; Theotikos, E; Tsakonas, G | 1 |
Iwaba, A; Kato, T; Nagaoka, A; Naito, S; Sakurai, T; Tomita, Y; Tsukigi, M; Yamagishi, A; Yamakawa, M | 1 |
Agarwala, S; Bisoi, AK; Das, S; Gupta, AK; Malankar, DP; Munghate, G; Sugandhi, N | 1 |
Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
Patel, S; Rao, P; Richey, SL; Tannir, NM; Wood, CG | 1 |
Bissett, D; Culligan, D; Petty, R | 1 |
Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
Debelenko, L; Granowetter, L; Hensle, TW; Lam, JS; Tennenbaum, SY | 1 |
Laberge, JM | 1 |
Hitchcock, RJ; Mitchell, CD; Patel, Y | 1 |
Ayuso, MJ; Cortés, F; López-Lázaro, M; Martín-Cordero, C; Navarro, E; Palma De La Peña, N; Pastor, N; Toro, MV | 1 |
Goto, H; Hanibuchi, M; Miki, T; Sone, S; Uehara, H; Yano, S; Zhang, H | 1 |
Fujinami, K; Fukuoka, H; Ikeda, I; Kawakami, S; Miura, T; Takizawa, A | 1 |
Cook, A; Izawa, JI; Mack, DP; Moussa, M | 1 |
Campbell, AD; Cohn, SL; Duerst, R; Geissler, G; Haut, PR; Kalapurakal, J; Kletzel, M; Marymount, M; Morgan, E; Rademaker, A; Reynolds, M; Seshadri, R | 1 |
Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
Dörken, B; Hildebrandt, B; Lippek, F; Mapara, MY; Oertel, S; Plotkin, M; Riess, H; Royer-Pokora, B; Schumacher, V; Trappe, RU; Zuber, J | 1 |
Fukui, I; Hanada, E; Ishikawa, Y; Nakagawa, K; Okubo, Y; Satoh, Y; Tadokoro, M; Tsukamoto, T; Yonese, J | 1 |
Maxwell, SA; Rivera, A | 1 |
Hara, Y; Hasegawa, A; Hattori, Y; Matsuura, K | 1 |
Forbes, TJ; Paules, M; Singh, HR; Zilberman, MV | 1 |
Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; Dome, JS; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Kalapurakal, JA; Kletzel, M; Macklis, RM; Malogolowkin, M; Perlman, EJ; Ritchey, ML; Shamberger, RC; Weetman, RM | 1 |
Dome, JS; Hareyama, M; Hatakeyama, N; Hirama, T; Hori, T; Kudoh, T; Kuroiwa, Y; Matsuno, T; Mizue, N; Nui, A; Oda, T; Suzuki, N; Tsutsumi, H; Yamamoto, M; Yokoyama, S | 1 |
Bayless, KJ; Davis, GE; Mavila, A; Maxwell, SA; Rivera, A | 1 |
Breslow, NE; Feusner, JH; Green, DM; Norkool, PA; Ritchey, ML; Takashima, JR | 1 |
Bhatia, A; Kumar, V; Kumar, Y; Vaiphei, K | 1 |
Hussein, MR; Omer, HA | 1 |
Fujimoto, K; Hirao, Y; Matsushita, C; Miyake, M; Tanaka, M; Tanaka, N | 1 |
Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; D'Angio, GJ; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Huff, V; Kletzel, M; Macklis, R; Malogolowkin, M; Miser, J; Newbury, R; Perlman, E; Ritchey, ML; Shamberger, RC; Shearer, P; Thomas, PR; Tomlinson, G; Weeks, D; Weetman, R | 1 |
Chan, JK; Chan, WK; Epstein, RJ; Leong, CH; Liang, RH; Yau, T | 1 |
Choi, YH; Kim, SH; Kwon, TK; Lee, JT; Lee, TJ; Park, JW; Song, KS | 1 |
Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ | 1 |
Fujita, K; Murayama, T; Sayama, T | 1 |
Endo, M; Tanosaki, R | 1 |
Hamburger, AW; Mishra, S | 1 |
Cowie, FJ; Dick, G; Flanagan, RJ; Judson, I; McCarthy, PT; Phillips, M; Pinkerton, CR | 1 |
Bassukas, ID; Hofmockel, G; Maurer-Schultze, B | 1 |
Douglass, EC; Jones, DP; Marina, NM; Meyer, WH; Pratt, CB; Wilimas, JA | 1 |
Kobayashi, H; Obata, K | 1 |
Boutard, P; Brunat-Mentigny, M; Deville, A; Dusol, F; Gentet, JC; Legall, E; Mechinaud, F; Pein, F; Tournade, MF; Zucker, JM | 1 |
Arakawa, S; Gotoh, A; Kamidono, S; Kitazawa, S; Maeda, S; Matsuwari, S; Mizuno, Y | 1 |
Bassukas, ID; Heimbach, D; Hofmockel, G; Maurer-Schultze, B; Wirth, M | 1 |
de Veber, LL; Del Maestro, RF; Ramsay, DA; Sahjpaul, RL | 1 |
Cornelius, AS; Murry, DJ; Teresi, ME | 1 |
Brunat-Mentigny, M; Levitt, G; Margueritte, G; Pein, F; Pinkerton, R; Rubie, H; Sommelet, D; Thyss, A; Tournade, MF; Zücker, JM | 1 |
Hashimoto, H; Iuchi, H; Morikawa, M; Numata, A; Tokumitsu, M; Yachiku, S; Yamauchi, K | 1 |
Aikawa, K; Irisawa, C; Ishibashi, K; Ishiwata, H; Koseki, K; Ogihara, M; Shiraiwa, Y | 1 |
Blute, ML; Lerner, SE; Richardson, RL; Zincke, H | 1 |
Esen, A; Giiler, C; Kargi, A; Kirkali, Z | 1 |
Akaza, H; Kawai, K | 1 |
Baek, SY; Choi, GB; Choi, JH; Han, WS; Shim, KN; Sung, SH | 1 |
Beck, WT; Mickisch, GH; Romijn, JC; Scheltema, JM; Schröder, FH; van Steenbrugge, GJ | 1 |
Baltaci, S; Beksac, M; Küpeli, B; Küpeli, S; Süzer, O | 1 |
Goessl, C; Heicappell, R; Miller, K; Müller, M; Steiner, U | 1 |
Fink, FM; Heitger, A; Maurer, K; Niederweiser, D; Schwaighofer, H | 1 |
Baranzelli, MC; Bergeron, C; Boutard, P; Frappaz, D; Gentet, JC; Hartmann, O; Michon, J; Pein, F; Philip, T; Quintana, E; Stephan, JL; Thyss, A; Tournade, MF; Valteau-Couanet, D; Vannier, JP; Zucker, JM | 1 |
Akaza, H; Tsukamoto, S | 1 |
Biserte, J; Blois, N; Colomb, JB; Goullet, E; Mazeman, E | 1 |
Goehle, S; Lamb, JR; Ludlow, C; Simon, JA | 1 |
Houghton, JB; O'Donoghue, DJ; O'Riordan, E; Reeve, R; Waldek, S | 1 |
Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
Hanafusa, T; Hosokawa, Y; Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M | 1 |
Azuhata, T; Davidoff, A; Fukuzawa, M; Sandler, A; Scott, D; Takamizawa, S; Wen, J | 1 |
Albertini, MR; Becker, BN; Bodvarsson, S; Burlingham, W; Hafez, GR; Kusaka, S; Pintar, T; Sollinger, HW | 1 |
Fushimi, H; Nakajima, S; Obana, T; Okuda, K; Takenaka, M; Tanio, Y; Tsubakihara, Y; Watanabe, D; Yanagita, M | 1 |
Abu-Ghosh, AM; Cairo, MS; Davenport, V; Goldman, SC; Krailo, MD; Laver, JH; Morris, E; Reaman, GH; Slack, RS | 1 |
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K | 1 |
Antoniolli, SZ; Curti, P; D'Amico, A; Ficarra, V; Malossini, G; Martignoni, G; Matteo, B; Novella, G; Porcaro, AB | 1 |
Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J | 1 |
Hosaka, M; Ikegami, I; Sano, K; Shiomi, Y; Shuuin, T | 1 |
Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y | 1 |
Kondo, I; Miura, T; Murai, T; Shimura, H | 1 |
de Dycker, RP; Fechtig, A; Neumann, RL; Schumacher, T; Zajaczkowski, T | 1 |
Lakomek, M; Schröter, W; Walka, MM | 1 |
Abratt, RP; du Preez, HM; Kaschula, R | 1 |
Larsson, R; Nygren, P | 1 |
Donaldson, JT; Keane, TE; Poulton, SH; Walther, PJ | 1 |
Alexander, RB; Burgers, JK; Coffey, DS; Isaacs, JT; Isaacs, WB; Kyprianou, N; Marshall, FF; Mohler, JL; Partin, AW | 1 |
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 1 |
Burgers, JK; Isaacs, JT; Marshall, FF | 1 |
Atkins, JN; Capizzi, RL; Caponera, ME; Craig, JB; Jackson, DV; Muss, HB; Powell, BL; Richards, F; White, DR; Zekan, PJ | 1 |
De Brabander, M; Distelmans, W; Van Ginckel, R; Vanherck, W | 1 |
13 review(s) available for etoposide and Kidney Neoplasms
Article | Year |
---|---|
Clinical study on carboplatin for treating pediatric patients with Wilms tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Treatment Outcome; Wilms Tumor | 2014 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
[A case of well controlled renal small cell carcinoma with metastasis treated by intensive therapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Kidney Neoplasms; Male; Nephrectomy | 2004 |
[A case of small cell carcinoma of kidney; solitary splenic metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Nephrectomy; Splenic Neoplasms | 2005 |
[Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carboplatin; Child; Combined Modality Therapy; Cryopreservation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Neoplasms; Neuroblastoma; Rhabdomyosarcoma; Wilms Tumor | 1995 |
Brain metastasis from clear cell sarcoma of the kidney--a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Frontal Lobe; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Vincristine | 1993 |
Ifosfamide-induced hyperpigmentation.
Topics: Child, Preschool; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Mesna; Pigmentation Disorders; Wilms Tumor | 1993 |
[The role of etoposide therapy in urogenital cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1996 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[A case of adult Wilms' tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nephrectomy; Treatment Outcome; Wilms Tumor | 2001 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2002 |
Primary lymphoma of the kidney. Report of a case and update of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Nephrectomy; Prednisone; Vincristine | 2002 |
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Movement; Etoposide; Humans; Kidney Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
9 trial(s) available for etoposide and Kidney Neoplasms
Article | Year |
---|---|
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney Neoplasms; Male; Neoplasm Staging; Recurrence; Wilms Tumor | 2008 |
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor | 2008 |
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasms; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhabdomyosarcoma; Sarcoma, Ewing; Verapamil; Wilms Tumor | 1995 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Staging; Remission Induction; Thrombocytopenia; Wilms Tumor | 1994 |
Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
Topics: Adolescent; Adult; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Treatment Outcome; Wilms Tumor | 1993 |
Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Wilms Tumor | 2002 |
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols | 1979 |
Results of adjuvant chemotherapy for invasive uroepithelial cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1992 |
89 other study(ies) available for etoposide and Kidney Neoplasms
Article | Year |
---|---|
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Ileal Neoplasms; KB Cells; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Ovarian Neoplasms; Plant Leaves; Plant Stems; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Taiwan; Tumor Cells, Cultured; Vincristine | 2001 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers.
Topics: Carrier Proteins; Etoposide; Humans; Hydroxyurea; Kidney Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction | 2023 |
Isobaric tags for relative and absolute quantitation-based quantitative proteomic analysis of X-linked inhibitor of apoptosis and H2AX in etoposide-induced renal cell carcinoma apoptosis.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Etoposide; Histones; Humans; Kidney Neoplasms; Proteomics; X-Linked Inhibitor of Apoptosis Protein | 2019 |
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Carrier Proteins; Cells, Cultured; Drug Resistance, Neoplasm; Energy Metabolism; Etoposide; Humans; Kidney; Kidney Neoplasms; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NADPH Oxidase 4; p300-CBP Transcription Factors; Reactive Oxygen Species; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Xenograft Model Antitumor Assays | 2017 |
XIAP underlies apoptosis resistance of renal cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; RNA Interference; RNA, Small Interfering; X-Linked Inhibitor of Apoptosis Protein | 2018 |
High-dose chemotherapy without whole lung radiation for refractory pulmonary metastases in an infant with stage IV favorable histology Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Etoposide; Humans; Infant; Kidney Neoplasms; Lung Neoplasms; Male; Melphalan; Wilms Tumor | 2018 |
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Sickle Cell Trait; Transplantation, Autologous | 2018 |
Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Kidney Neoplasms; Male; Prognosis; Prospective Studies; Sarcoma, Clear Cell; Survival Rate | 2019 |
[Atypical clinical presentation of a neuroblastoma in an infant].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Constipation; Dexamethasone; Diagnosis, Differential; Etoposide; Female; Follow-Up Studies; Humans; Infant; Inpatients; Kidney Neoplasms; Lumbar Vertebrae; Neoplasm Staging; Neuroblastoma; Paraparesis; Peripheral Nervous System Neoplasms; Phosphopyruvate Hydratase; Radiography; Rectal Prolapse; Spinal Nerve Roots; Treatment Outcome | 2013 |
Structural elaboration of a natural product: identification of 3,3'-diindolylmethane aminophosphonate and urea derivatives as potent anticancer agents.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Etoposide; Humans; Immunohistochemistry; Indoles; Kidney Neoplasms; Molecular Structure; Organophosphorus Compounds | 2013 |
Teratoid Wilms' tumor exhibiting extensive squamous differentiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Differentiation; Child; Etoposide; Hematuria; Humans; Kidney Neoplasms; Male; Remission Induction; Teratoma; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Transplantation Conditioning; Vincristine; Wilms Tumor | 2014 |
Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Proteolysis; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Signal Transduction; Tumor Suppressor Protein p53 | 2015 |
Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Favorable Histology Wilms Tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Immunoglobulins, Intravenous; Kidney Neoplasms; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Neoadjuvant Therapy; Nephrectomy; Remission Induction; Vincristine; Wilms Tumor | 2015 |
A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
Topics: Abdominal Neoplasms; Acute Lung Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Etoposide; Fluoroscopy; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Postoperative Complications; Prosthesis Implantation; Radiography, Thoracic; Radiotherapy; Respiratory Distress Syndrome; Transfusion Reaction; Vascular Access Devices | 2015 |
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine | 2016 |
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Digestive System Neoplasms; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Hysterectomy; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Methotrexate; Pelvis; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Hemorrhage; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Infant; Kidney Neoplasms; Kidney Tubules; Linear Models; Male; Nephrectomy; Prospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Melphalan; Prognosis; Rhabdoid Tumor; Survival Rate; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Preoperative Care; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Receptor, IGF Type 1; RNA, Small Interfering; Sirolimus; Transfection; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2009 |
[Successful response of reccurent adult wilms' tumor to multiagent chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Vincristine; Wilms Tumor; Young Adult | 2009 |
A rare case of simultaneous occurrence of Wilms' tumor in the left kidney and the bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Infant; Kidney Neoplasms; Male; Neoplasms, Multiple Primary; Ultrasonography; Urinary Bladder Neoplasms; Vincristine; Wilms Tumor | 2010 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Salvage Therapy; Wilms Tumor | 2010 |
Second high-dose chemotherapy intensification followed by hematopoietic stem cell transplantation applying a novel high-dose topotecan-based regimen in an adult Wilms' tumor patient: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Nephrectomy; Topotecan; Wilms Tumor; Young Adult | 2011 |
[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].
Topics: Adult; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Treatment Outcome; Wilms Tumor | 2011 |
Pediatric clear cell sarcoma of the kidney with cavoatrial thrombus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiopulmonary Bypass; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Heart Atria; Hepatic Veins; Humans; Kidney Neoplasms; Male; Neoadjuvant Therapy; Nephrectomy; Sarcoma, Clear Cell; Thrombectomy; Tomography, X-Ray Computed; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis; Vincristine; Wilms Tumor | 2011 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Induction Chemotherapy; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Radiography; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2012 |
Successful salvage of relapsed adults Wilms' tumour with high dose chemotherapy and autologous peripheral blood stem cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Wilms Tumor | 2002 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Organ-confined primitive neuroectodermal tumor arising from the kidney.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Nephrectomy; Neuroectodermal Tumors, Primitive; Remission Induction; Vincristine; Weight Loss | 2003 |
Nephroblastomatosis update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Kidney Neoplasms; Male; Vincristine; Wilms Tumor | 2003 |
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Liver Neoplasms; Nephroma, Mesoblastic; Sarcoma; Vincristine | 2003 |
Anti-tumour activity of Digitalis purpurea L. subsp. heywoodii.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cardenolides; Cell Line, Tumor; Digitalis; Digoxin; Etoposide; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Phytotherapy; Plant Extracts; Plant Leaves | 2003 |
Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Carcinoma, Small Cell; Cell Division; Diphosphonates; Drug Combinations; Etoposide; Humans; Imidazoles; Kidney Neoplasms; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred ICR; Mice, SCID; Osteoclasts; Parathyroid Hormone-Related Protein; Survival Rate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2003 |
Metastatic Merkel cell tumor to the prostate and bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Palliative Care; Prostatic Neoplasms; Radiotherapy, Adjuvant; Spinal Neoplasms; Transurethral Resection of Prostate; Urethral Obstruction; Urinary Bladder Neoplasms | 2004 |
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome; Wilms Tumor | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Genes, Wilms Tumor; Germ-Line Mutation; Humans; Kidney Neoplasms; Male; Melphalan; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Wilms Tumor | 2004 |
Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Middle Aged; Salvage Therapy | 2005 |
The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway.
Topics: Apoptosis; Blotting, Western; Calcineurin; Calcium; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclosporine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Etoposide; Genes, Reporter; Green Fluorescent Proteins; Humans; Kidney Neoplasms; Luciferases; NFATC Transcription Factors; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Oligonucleotides, Antisense; Plasmids; Proline Oxidase; Reactive Oxygen Species; Tacrolimus; Transcription Factors; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2005 |
Reversible dilated cardiomyopathy and neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiomyopathy, Dilated; Etoposide; Female; Humans; Infant; Kidney Neoplasms; Neuroblastoma | 2005 |
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Topics: Adolescent; Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Prognosis; Prospective Studies; Radiotherapy; Rhabdoid Tumor; Sarcoma, Clear Cell; Survival Analysis; Vincristine; Wilms Tumor | 2006 |
Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Remission Induction; Rhabdoid Tumor; Vincristine | 2006 |
Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells.
Topics: Apoptosis; CDC2 Protein Kinase; Cyclin A; Cyclin A1; Cyclin A2; DNA, Neoplasm; Etoposide; Female; G2 Phase; Gene Expression Profiling; Humans; Kidney Neoplasms; Lung Neoplasms; Mitosis; Mutation; Ovarian Neoplasms; Polyploidy; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2006 |
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Renal Insufficiency; Treatment Outcome; Vincristine; Wilms Tumor | 2008 |
Intrarenal pure yolk sac tumor: an extremely rare entity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Disease-Free Survival; Endodermal Sinus Tumor; Etoposide; Humans; Infant; Kidney Neoplasms; Male; Periodic Acid-Schiff Reaction; Treatment Outcome; Wilms Tumor | 2007 |
Primary renal lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Urea Nitrogen; Creatine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Prednisone; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2007 |
A case of small cell carcinoma of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Irinotecan; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Piperidines | 2007 |
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Hemangiosarcoma; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2008 |
Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells.
Topics: Adenocarcinoma, Clear Cell; Amino Acid Chloromethyl Ketones; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Division; Cell Line, Tumor; Endoplasmic Reticulum; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Recombinant Fusion Proteins; Thapsigargin; TNF-Related Apoptosis-Inducing Ligand; Transfection; X-Linked Inhibitor of Apoptosis Protein | 2008 |
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Topics: Animals; Cachexia; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypopharyngeal Neoplasms; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Recombinant Proteins; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 1995 |
Refining therapeutic strategies for patients with resistant Wilm's tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Medical Records; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Wilms Tumor | 1994 |
[Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1994 |
Treatment of a human renal cell carcinoma in nude mice with recombinant human tumor necrosis factor alpha and etoposide.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1993 |
[Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1996 |
[Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cisplatin; Collagen; Culture Media; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred C3H; Mitomycin; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Kidney Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome; Ureteral Neoplasms; Vinblastine | 1996 |
Cisplatin and etoposide chemotherapy in the treatment of adult Wilms' tumor.
Topics: Chemotherapy, Adjuvant; Cisplatin; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Humans; Kidney; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Wilms Tumor | 1996 |
Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lymphoma, Follicular; Male; Methotrexate; Neoplasms, Multiple Primary; Prednisone; Remission Induction; Vincristine | 1997 |
Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Renal Cell; DNA Methylation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Humans; Isoenzymes; Kidney Neoplasms; Polymorphism, Single-Stranded Conformational; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vinblastine | 1997 |
Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cell Division; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Tumor Cells, Cultured; Vinblastine; Vincristine | 1997 |
Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Salvage Therapy; Vincristine; Wilms Tumor | 1997 |
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Wilms Tumor | 1998 |
[A case of metastatic nephroblastoma in an adult with favorable outcome under cisplatyl, etoposide].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Tomography, X-Ray Computed; Treatment Outcome; Wilms Tumor | 1999 |
Thymidine incorporation is highly predictive of colony formation and can be used for high-throughput screening.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chickens; CHO Cells; Colonic Neoplasms; Colony-Forming Units Assay; Cricetinae; Drug Screening Assays, Antitumor; Etoposide; Humans; Hydroxyurea; Kidney Neoplasms; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Thymidine; Tritium; Tumor Cells, Cultured | 2001 |
Primary bilateral T-cell renal lymphoma presenting with sudden loss of renal function.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Bell Palsy; Bleomycin; Creatinine; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Kidney Neoplasms; Lymphoma, T-Cell; Male; Middle Aged; Vincristine | 2001 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Cycle; Chromosomal Proteins, Non-Histone; Cysteine Proteinase Inhibitors; Etoposide; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Kidney Neoplasms; Membrane Glycoproteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neuroblastoma; RNA, Messenger; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |
Donor-derived small cell lung carcinoma in a kidney transplant recipient.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cushing Syndrome; Etoposide; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Kidney Neoplasms; Kidney Transplantation; Tissue Donors | 2001 |
[Chemotherapy for small-cell lung cancer (SCLC) patients with renal failure].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Polyneuropathy; Renal Dialysis; Renal Insufficiency | 2002 |
[A preliminary study to determine the activity of topoisomerase II in human kidney cancer cells with DNA unknotting method].
Topics: DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Humans; Kidney Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
[MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1992 |
[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy, Vaginal; Kidney Neoplasms; Methotrexate; Nephrectomy; Pregnancy; Uterine Neoplasms; Vincristine | 1992 |
[Complete remission of a highly malignant, progressive under therapy Wilm's tumor using the combination carboplatin and etoposide (VP 16)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Nephrectomy; Remission Induction; Wilms Tumor | 1991 |
Adult Wilms' tumor. Cisplatin and etoposide for relapse after adjuvant chemotherapy.
Topics: Adult; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Prognosis; Vincristine; Wilms Tumor | 1990 |
Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Topics: Adenocarcinoma; Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Line; Cell Survival; Cisplatin; Cyclosporins; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lymphocytes; Methionine Sulfoximine; Neurilemmoma; Tumor Cells, Cultured; Verapamil; Vincristine | 1991 |
Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Humans; Immunotherapy; Kidney Neoplasms; Mice; Mice, Nude; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1990 |
[Plasma methotrexate concentrations in urothelial cancer chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in a xenograft model.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Humans; Kidney Neoplasms; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Nephrectomy; Recombinant Proteins; Remission Induction; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1989 |
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cytarabine; Drug Evaluation; Etoposide; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged | 1987 |
The Kidney Invasion Test: an assay allowing macroscopic quantification of malignant invasion in vivo. Comparison between the microtubule inhibitor tubulozole and the podophyllotoxin congener etoposide (VP-16-213).
Topics: Animals; Cell Division; Dioxolanes; Dioxoles; Drug Evaluation, Preclinical; Etoposide; Kidney Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Podophyllotoxin | 1985 |
[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Topics: Administration, Oral; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Male; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urogenital Neoplasms | 1985 |